A controlled clinical trial was carried out in which three drug regimens, rifampicin plus isoniazid, rifampicin plus PAS, and isoniazid plus PAS, administered for 6 months, were compared in patients with newly diagnosed pulmonary tuberculosis. The drugs were given in the following doses: rifampicin, 450 mg up to 60 kg and 600 mg over 60 kg body weight in one dose; isoniazid, 5 mg/kg in one dose; PAS, 10 g up to 60 kg and 12 g over 60 kg body weight, divided in two doses. Bacteriological results showed that all the treatment regimens had a similar efficacy. In the groups of patients who were administered rifampicin, faster disappearance of tubercle bacilli from sputum was observed. The roentgenographic changes were comparable in all groups. According to the results obtained, rifampicin is a drug whose effectiveness and tolerability are comparable with those of isoniazid.

This content is only available via PDF.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.